BORIS/CTCFL mRNA isoform expression and epigenetic regulation in epithelial ovarian cancer

Cancer immunity

Adam R. Karpf¹  Kunle Odunsi²  Wa Zhang¹  Petra A. Link¹ 

[1] Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USADepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USADepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA;Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY, USADepartment of Immunology, Roswell Park Cancer Institute, Buffalo, NY, USACenter for Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY, USA Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY, USADepartment of Immunology, Roswell Park Cancer Institute, Buffalo, NY, USACenter for Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY, USADepartment of Immunology, Roswell Park Cancer Institute, Buffalo, NY, USA Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY, USADepartment of Immunology, Roswell Park Cancer Institute, Buffalo, NY, USACenter for Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY, USACenter for Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY, USA Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY, USADepartment of Immunology, Roswell Park Cancer Institute, Buffalo, NY, USACenter for Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY, USA

关键词: ovarian cancer;    epigenetics;    BORIS;    DNA methylation;    CTCF;   

DOI  :  

学科分类：肿瘤学

来源: Cancer immunity

【 授权许可】

Unknown